What's new

Human medicines European public assessment report (EPAR): Avonex, interferon beta-1a, Date of authorisation: 13/03/1997, Revision: 39, Status: Authorised

Human medicines European public assessment report (EPAR): Avonex, interferon beta-1a, Date of authorisation: 13/03/1997, Revision: 39, Status: Authorised

Apr 10, 2025 - 15:36
 0
Human medicines European public assessment report (EPAR): Avonex, interferon beta-1a, Date of authorisation: 13/03/1997, Revision: 39, Status: Authorised
Human medicines European public assessment report (EPAR): Avonex, interferon beta-1a, Date of authorisation: 13/03/1997, Revision: 39, Status: Authorised
Read More

Tags:

Previous Article

Human medicines European public assessment report (EPAR): Akynzeo, netupitant,pa...

Next Article

Human medicines European public assessment report (EPAR): Trepulmix, treprostini...

Related Posts

Human medicines European public assessment report (EPAR): Skytrofa (previously Lonapegsomatropin Ascendis Pharma), lonapegsomatropin, Date of authorisation: 11/01/2022, Revision: 5, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 12, 2025  0

Human medicines European public assessment report (EPAR): Rukobia, fostemsavir, Date of authorisation: 04/02/2021, Revision: 5, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 31, 2025  0

Human medicines European public assessment report (EPAR): Osvyrti, denosumab, Status: Opinion

Human medicines European public assessment report (EPAR...

Mar 28, 2025  0